Historical Stock Price
ETFs Holding SYRS »    Stock Splits Calendar »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
08/11/2022 $0.97 $0.99 $0.86 $0.93 1.12M
08/12/2022 $0.92 $0.98 $0.90 $0.95 572.60K
08/15/2022 $0.92 $1.01 $0.92 $1.01 619.30K
08/16/2022 $0.99 $1.01 $0.95 $0.97 522.10K
08/17/2022 $0.95 $0.98 $0.91 $0.91 298.50K
Syros Pharmaceuticals is a biopharmaceutical company focused on developing treatments for cancer and diseases resulting from mutations of a single gene, also known as monogenic diseases, and building a clinical stage pipeline of gene control medicines. Co.'s primary product candidates are: Tamibarotene, which is a selective retinoic acid receptor alpha agonist that is being evaluated in combination with azacitidine; SY-2101, which is an oral form of arsenic trioxide; and SY-5609, which is a selective oral inhibitor of cyclin-dependent kinase 7 that is being evaluated in combination with chemotherapy in relapsed/refractory metastatic pancreatic cancer patients.
SYRS historical stock prices picture
Syros Pharmaceuticals (SYRS) has the following price history information. Looking back at SYRS historical stock prices for the last five trading days, on August 11, 2022, SYRS opened at $0.97, traded as high as $0.99 and as low as $0.86, and closed at $0.93. Trading volume was a total of 1.12M shares. On August 12, 2022, SYRS opened at $0.92, traded as high as $0.98 and as low as $0.90, and closed at $0.95. Trading volume was a total of 572.60K shares. On August 15, 2022, SYRS opened at $0.92, traded as high as $1.01 and as low as $0.92, and closed at $1.01. Trading volume was a total of 619.30K shares. On August 16, 2022, SYRS opened at $0.99, traded as high as $1.01 and as low as $0.95, and closed at $0.97. Trading volume was a total of 522.10K shares. On August 17, 2022, SYRS opened at $0.95, traded as high as $0.98 and as low as $0.91, and closed at $0.91. Trading volume was a total of 298.50K shares.

SYRS Historical Stock Prices By Date:

SYRS historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Syros Pharmaceuticals shares, starting with a $10,000 purchase of SYRS, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/01/2016
End date: 08/17/2022
Start price/share: $19.35
End price/share: $0.91
Dividends collected/share: $0.00
Total return: -95.29%
Average Annual Total Return: -39.24%
Starting investment: $10,000.00
Ending investment: $471.25
Years: 6.13
Date Close
08/11/2022$0.93
08/12/2022$0.95
08/15/2022$1.01
08/16/2022$0.97
08/17/2022$0.91
SYRS is categorized under the Healthcare sector; below are some other companies in the same sector:

TARO Historical Stock Prices
TBIO Historical Stock Prices
TBRA Historical Stock Prices
TCMD Historical Stock Prices
TCON Historical Stock Prices
TDOC Historical Stock Prices
TEAR Historical Stock Prices
TECH Historical Stock Prices
TELK Historical Stock Prices
TENX Historical Stock Prices

Also explore: SYRS shares outstanding history

Email EnvelopeFree SYRS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

SYRS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.